Author:
Zucco Adrian G.,Agius Rudi,Svanberg Rebecka,Moestrup Kasper S.,Marandi Ramtin Z.,MacPherson Cameron Ross,Lundgren Jens,Ostrowski Sisse R.,Niemann Carsten U.
Abstract
AbstractInterpretable risk assessment of SARS-CoV-2 positive patients can aid clinicians to implement precision medicine. Here we trained a machine learning model to predict mortality within 12 weeks of a first positive SARS-CoV-2 test. By leveraging data on 33,938 confirmed SARS-CoV-2 cases in eastern Denmark, we considered 2723 variables extracted from electronic health records (EHR) including demographics, diagnoses, medications, laboratory test results and vital parameters. A discrete-time framework for survival modelling enabled us to predict personalized survival curves and explain individual risk factors. Performance on the test set was measured with a weighted concordance index of 0.95 and an area under the curve for precision-recall of 0.71. Age, sex, number of medications, previous hospitalizations and lymphocyte counts were identified as top mortality risk factors. Our explainable survival model developed on EHR data also revealed temporal dynamics of the 22 selected risk factors. Upon further validation, this model may allow direct reporting of personalized survival probabilities in routine care.
Funder
Danmarks Grundforskningsfond
Uddannelses- og Forskningsministeriet
Publisher
Springer Science and Business Media LLC
Reference68 articles.
1. Coronavirus Disease (COVID-19): Weekly Epidemiological Update (20 April 2022) World. ReliefWeb https://reliefweb.int/report/world/coronavirus-disease-covid-19-weekly-epidemiological-update-20-april-2022.
2. Yang, R., Gui, X. & Xiong, Y. Comparison of clinical characteristics of patients with asymptomatic vs symptomatic coronavirus disease 2019 in Wuhan, China. JAMA Netw. Open 3, e2010182 (2020).
3. Wu, Z. & McGoogan, J. M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72314 cases from the Chinese center for disease control and prevention. JAMA 323, 1239–1242 (2020).
4. Guan, W. et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 382, 1708–1720 (2020).
5. Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan,China. The Lancet 395, 497–506 (2020).
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献